Serum Institute of India, the world’s largest vaccine manufacturer, will soon start clinical trials in the country to test if tuberculosis vaccine VPM1002 is effective as a preventive and immunity booster vaccine against Covid-19.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2wzHZD2
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Serum Institute to test if TB vaccine VPM1002 is effective against Covid-19
0 comments:
Post a Comment